| Quarter | Prior | Estimate | Actual | Surprise | |
|---|---|---|---|---|---|
| Q3 2021 Pre-Market | EPS: REV: | 0.33 125.529M | |||
| Q2 2021 Pre-Market | EPS: REV: | ||||
| Q1 2021 Pre-Market | EPS: REV: | 2.57 168.831M | |||
| Q4 2020 Pre-Market | EPS: REV: | 1.72 118.918M | 1.15 232.16M | ||
| Q3 2020 Pre-Market | EPS: REV: | 0.67 83.909M | 0.32 139.13M | 0.33 125.529M | 3.12% -9.78% |
| Q2 2020 Pre-Market | EPS: REV: | 0.16 65.959M | -0.03 111.37M | 0.47 133.518M | 1666.67% 19.89% |
| Q1 2020 Pre-Market | EPS: REV: | 0.81 81.204M | 1.61 150.5M | 2.57 168.831M | 59.63% 12.18% |
| Q4 2019 Pre-Market | EPS: REV: | 1.16 75.603M | 0.91 118.8M | 1.72 118.918M | 89.01% 0.1% |
| Q3 2019 Pre-Market | EPS: REV: | 0.32 67.39M | 0.43 85.6M | 0.67 83.909M | 55.81% -1.98% |
| Q2 2019 Pre-Market | EPS: REV: | 1.36 66.953M | -0.11 69.8M | 0.16 65.959M | 245.45% -5.5% |
Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!
News Coverage
- RBC: Keurig Dr Pepper Growth 'Gets Another Jolt', 'Monster' Results From Monster Beverage
- The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
- Warren Buffett In Annual Letter Signals More Stock Buybacks Coming This Year, Says Don't 'Bet Against America'
- 4 Workday Analysts Break Down Earnings, Look Ahead To Fiscal 2022
- Rocket Companies 'Firing On All Cylinders,' BofA Says After Q4 Print
- Will Nio's Sagging Stock Get a Lift From Earnings? A Q4 Preview
- PreMarket Prep Stock Of The Day: DoorDash
- Mid-Afternoon Market Update: Crude Oil Down Over 3%; AMC Networks Shares Surge After Q4 Results
- 4 Airbnb Stock Analysts On Q4 Results, 2021 Outlook: 'The Best Way To Play A Travel Recovery'
- NIO Prepares To Report Q4 Earnings As Shares Retreat From Recent Highs
